Herbin S R, Klepser D G, Klepser M E
College of Pharmacy, Ferris State University, Big Rapids, Michigan, USA.
College of Pharmacy, University of Nebraska Medical Center, Omaha, Nebraska, USA.
J Clin Microbiol. 2020 Apr 23;58(5). doi: 10.1128/JCM.00726-19.
There are roughly 48,000 deaths caused by influenza annually and an estimated 200,000 people who have undiagnosed human immunodeficiency virus (HIV). These are examples of acute and chronic illnesses that can be identified by employing a CLIA-waived test. Pharmacies across the country have been incorporating CLIA-waived point-of-care tests (POCT) into disease screening and management programs offered in the pharmacy. The rationale behind these programs is discussed. Additionally, a summary of clinical data for some of these programs in the infectious disease arena is provided. Finally, we discuss the future potential for CLIA-waived POCT-based programs in community pharmacies.
每年约有48000人死于流感，估计有20万人感染了未被诊断出的人类免疫缺陷病毒（HIV）。这些都是可以通过采用免临床实验室改进修正案（CLIA）检测来识别的急性和慢性疾病的例子。全国各地的药店已将免CLIA的即时检验（POCT）纳入药店提供的疾病筛查和管理项目中。本文讨论了这些项目背后的基本原理。此外，还提供了一些传染病领域此类项目的临床数据总结。最后，我们探讨了社区药店中基于免CLIA的POCT项目的未来潜力。
